Multicenter characterization of enterocolitis associated with BCMA-directed CAR T cell therapy
Immune effector cell-associated enterocolitis (IEC-EC) is a delayed toxicity of ciltacabtagene autoleucel. The US Multiple Myeloma Immunotherapy Consortium retrospectively adjudicated 54 suspected cases from 8 institutions: 41 were IEC-EC (31 confirmed by anti-camelid variable heavy-chain immunohistochemistry, 10 probable). Through September 2025, cumulative incidence was 3.0% (39 of 1,308 ciltacabtagene autoleucel recipients; 95% CI 2.1–4.1%); 12-month competing-risk incidence was 3.0% (95% CI 2.1–4.1%). Median symptom onset was 75 days after infusion. Grade ≥3 diarrhea occurred in 85% (34 of 40 with diarrhea); 73% (30 of 41) required parenteral nutrition. Despite normal upper endoscopy in 41% (9 of 22), duodenal biopsies showed villous blunting, apoptotic bodies and a dense cytotoxic T cell infiltrate, CD4 + in 61% (19 of 31), CD8 + in 26% (8 of 31) and mixed in 13% (4 of 31). A dominant T cell clone was detected in 76% (13 of 17 tested). Delayed neurotoxicity co-occurred in 41% (17 of 41). At last follow-up, 32% (13 of 41) resolved, 27% (11 of 41) had ongoing symptoms and 41% (17 of 41) died with active IEC-EC. Combined biologic and T cell-directed therapy yielded the highest resolution (55%, 6 of 11) in small subgroups. IEC-EC is potentially fatal and requires systematic evaluation and early directed therapy.
Authors
- Rebecca M. Gonzalez (ORCID: https://orcid.org/0000-0003-0024-0699)
- Ajai Chari (ORCID: https://orcid.org/0000-0002-0405-7480)
- Francisco Vega (ORCID: https://orcid.org/0000-0001-5956-452X)
- Sharlene Dong (ORCID: https://orcid.org/0000-0002-6983-6012)
- Mark P. Hamilton (ORCID: https://orcid.org/0000-0002-3732-8910)
- Jeffrey Lee Wolf (ORCID: https://orcid.org/0000-0003-4510-6485)
- Ghulam Rehman Mohyuddin (ORCID: https://orcid.org/0000-0001-6464-783X)
- Yi Lin (ORCID: https://orcid.org/0000-0002-1556-6416)
- Surbhi Sidana (ORCID: https://orcid.org/0000-0003-3288-7614)
- Frederick Lundry Locke (ORCID: https://orcid.org/0000-0001-9063-6691)
- Rahul Kumar Banerjee (ORCID: https://orcid.org/0000-0003-3781-5441)
- Hitomi Hosoya (ORCID: https://orcid.org/0000-0003-0475-9666)
- Alaa Ali
- Andrew Jay Portuguese (ORCID: https://orcid.org/0000-0003-1010-4578)
- Max N. Brondfield (ORCID: https://orcid.org/0000-0002-0435-3474)
- Alexandria M. Jensen (ORCID: https://orcid.org/0000-0001-6337-9079)
- Lekha Mikkilineni (ORCID: https://orcid.org/0009-0003-7698-5934)
- Nadine H. Abdallah (ORCID: https://orcid.org/0000-0001-9195-1589)
- Zongming Eric Chen (ORCID: https://orcid.org/0000-0002-8328-9350)
- Omar Alexis Castaneda Puglianini (ORCID: https://orcid.org/0000-0003-0423-5870)
- Doris K. Hansen (ORCID: https://orcid.org/0000-0002-9813-3578)
- Douglas Weston Sborov (ORCID: https://orcid.org/0000-0003-4268-2698)
- Amandeep Godara (ORCID: https://orcid.org/0000-0003-1943-4442)
- Sebastian Fernandez‐Pol (ORCID: https://orcid.org/0000-0002-0428-0199)
- Binod Dhakal (ORCID: https://orcid.org/0000-0002-4377-9742)
- David Yoonsuk Oh (ORCID: https://orcid.org/0000-0002-3310-0994)
- Kenneth J C Lim (ORCID: https://orcid.org/0000-0002-2664-116X)
- Krina K. Patel (ORCID: https://orcid.org/0000-0002-8894-027X)
- Dana J. Balitzer (ORCID: https://orcid.org/0000-0003-3819-478X)
- NAVREET M. CHOWLA (ORCID: https://orcid.org/0009-0009-8882-5579)
- Michael G. Kattah (ORCID: https://orcid.org/0000-0002-6067-6585)
- Anna Shestakova (ORCID: https://orcid.org/0000-0002-3471-5018)
- Metin Özdemirli (ORCID: https://orcid.org/0000-0002-1847-5165)
- Christopher James Ferreri (ORCID: https://orcid.org/0000-0003-2997-4856)
- David Bernard Miklos (ORCID: https://orcid.org/0000-0003-0717-4305)
- Louis S. Williams (ORCID: https://orcid.org/0000-0001-6680-4608)
- Thomas G Martin (ORCID: https://orcid.org/0000-0003-1752-5092)
- Christopher Bowman (ORCID: https://orcid.org/0000-0002-4107-4116)
- Jinming Song
- Anupama D. Kumar
- Gliceida M. Galarza-Fortuna
Institutions
- Cedars-Sinai Medical Center (US)
- Cleveland Clinic (US)
- Mayo Clinic (US)
- The University of Texas MD Anderson Cancer Center (US)
- University of California, San Francisco (US)
- Georgetown University (US)
- Medical College of Wisconsin (US)
- University of Utah (US)
- Georgetown University Medical Center (US)
- Huntsman Cancer Institute (US)
- Moffitt Cancer Center (US)
- Fred Hutch Cancer Center (US)
- Levine Cancer Institute (US)
- Stanford Medicine (US)
- Alfred Health (AU)
- Georgetown Lombardi Comprehensive Cancer Center (US)
- Wake Forest University (US)
- Monash University (AU)
- ARUP Laboratories (United States) (US)
- Stanford University (US)
Publication Details
- Journal
- Nature Medicine
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1038/s41591-026-04783-y
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00